Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
AC Immune (ACIU) had Weighted-Average Shares Outstanding (Diluted) of 100.75M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$0.45M |
|
$-18.36M |
|
-- |
|
$0.45M |
|
$18.87M |
|
$-18.42M |
|
$0.06M |
|
$-18.36M |
|
$-18.36M |
|
$-18.36M |
|
$-18.36M |
|
$-18.36M |
|
$-18.36M |
|
$-18.42M |
|
$-17.71M |
|
100.75M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
100.75M |
$-0.18 |
|
$-0.18 |
|
| Balance Sheet Financials | |
$116.74M |
|
$2.40M |
|
$69.44M |
|
$186.18M |
|
$114.29M |
|
-- |
|
$17.71M |
|
$132.01M |
|
$54.17M |
|
$-6.68M |
|
$54.17M |
|
101.74M |
|
| Cash Flow Statement Financials | |
$-83.60M |
|
$76.70M |
|
$-1.23M |
|
$43.78M |
|
$32.34M |
|
$-11.44M |
|
$5.31M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.02 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-4048.63% |
|
-4048.63% |
|
-- |
|
-4036.25% |
|
-4036.25% |
|
$-84.67M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
0.39 |
|
233.54 |
|
-33.89% |
|
275.00% |
|
-9.86% |
|
-33.89% |
|
$0.53 |
|
$-0.84 |
|
$-0.83 |
|